AKT1 and hepatocellular carcinoma: In conclusion, our study is the first to demonstrate the miR-32-5p delivered by exosomes from resistant cells, activates the PI3K/Akt pathway and leads to multidrug resistance in HCC via angiogenesis and EMT.